Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Clinical Data

Beam posts positive data on base editing treatment for AATD

 March 25, 2026

BioPharma Dive

Updated data showed the biotech’s approach to the rare lung and liver condition helped restore functional protective proteins in a small study.

Clinical DataRare DiseaseRead full story

Post navigation

Sarepta sees early success with RNAi drugs from Arrowhead →
← Maze tumbles despite positive data for kidney disease drug

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com